Skip to content
Twitter Linkedin
  • Home
  • About
    • About Boyds
    • Why Boyds
    • Our Team
    • Vision and Values
    • Boyds’ ESG Commitments
    • Working at Boyds
    • Join Us
  • Services
    • Regulatory Affairs
      • Filing in the US
      • Regulatory Affairs | UK and Europe
      • CMC Regulatory Affairs
      • Medical Devices
      • SME Status via Boyds
    • Clinical and Medical Affairs
      • Interim Chief Medical Officer
      • Medical Monitoring
      • Scientific and Medical Advice
      • Support for Medical Directors and Chief Medical Officers
      • Meet the Medics
    • Clinical Operations
      • Biostatistics
      • Clinical Project Management
      • Clinical Site Monitoring
      • Clinical Study Start-Up
    • Pharmaceutical Due Diligence
    • Product Development
      • Investor Readiness
    • Regulatory Operations and Publishing
      • Regulatory Submission Pathways
    • Regulatory and Medical Writing
    • Early Access Programs and Real-World Data Collection
    • My Development TEAM
  • Latest
    • News
    • Blogs
    • Case Studies
    • Events
    • Podcast | Conversations in Drug Development
  • Regulatory Updates
  • Resources
    • Factsheets
    • Publications
    • Webinars
  • Contact us
  • Home
  • About
    • About Boyds
    • Why Boyds
    • Our Team
    • Vision and Values
    • Boyds’ ESG Commitments
    • Working at Boyds
    • Join Us
  • Services
    • Regulatory Affairs
      • Filing in the US
      • Regulatory Affairs | UK and Europe
      • CMC Regulatory Affairs
      • Medical Devices
      • SME Status via Boyds
    • Clinical and Medical Affairs
      • Interim Chief Medical Officer
      • Medical Monitoring
      • Scientific and Medical Advice
      • Support for Medical Directors and Chief Medical Officers
      • Meet the Medics
    • Clinical Operations
      • Biostatistics
      • Clinical Project Management
      • Clinical Site Monitoring
      • Clinical Study Start-Up
    • Pharmaceutical Due Diligence
    • Product Development
      • Investor Readiness
    • Regulatory Operations and Publishing
      • Regulatory Submission Pathways
    • Regulatory and Medical Writing
    • Early Access Programs and Real-World Data Collection
    • My Development TEAM
  • Latest
    • News
    • Blogs
    • Case Studies
    • Events
    • Podcast | Conversations in Drug Development
  • Regulatory Updates
  • Resources
    • Factsheets
    • Publications
    • Webinars
  • Contact us
Boyds Home
Twitter Linkedin
  • Home
  • About

    About Boyds

    A global drug development consultancy supporting cutting-edge development.

    Find out more
    • About Boyds
    • Why Boyds
    • Our Team
    • About Boyds
    • Why Boyds
    • Our Team
    • Vision and Values
    • Boyds’ ESG Commitments
    • Working at Boyds
    • Join Us
    • Vision and Values
    • Boyds’ ESG Commitments
    • Working at Boyds
    • Join Us
  • Services
    • Regulatory Affairs
    • Filing in the US
    • Filing in the UK & Europe
    • CMC Regulatory Affairs
    • Medical Devices
    • SME Status via Boyds
    • Filing in the US
    • Filing in the UK & Europe
    • CMC Regulatory Affairs
    • Medical Devices
    • SME Status via Boyds
    • Regulatory Operations and Publishing
    • Regulatory Submission Pathways
    • Regulatory Submission Pathways
    • Product Development
    • Investor Readiness
    • Investor Readiness
    • Clinical and Medical Affairs
    • Interim Chief Medical Officer
    • Medical Monitoring
    • Scientific and Medical Advice
    • Support for Medical Directors and Chief Medical Officers
    • Meet the Medics
    • Interim Chief Medical Officer
    • Medical Monitoring
    • Scientific and Medical Advice
    • Support for Medical Directors and Chief Medical Officers
    • Meet the Medics
    • Clinical Operations
    • Biostatistics
    • Clinical Project Management
    • Clinical Site Monitoring
    • Clinical Study Start-Up Support
    • Biostatistics
    • Clinical Project Management
    • Clinical Site Monitoring
    • Clinical Study Start-Up Support
    • Regulatory and Medical Writing
    • Pharmaceutical Due Diligence
    • Early Access Programs and Real-World Data Collection

    Why Boyds?

    Boyds Drug Development Consultancy
  • Latest
    Conversations in Drug Development

    Latest Podcast

    Listen to the latest podcast episode of Conversation in Drug Development

    • News
    • Blogs
    • Case Studies
    • News
    • Blogs
    • Case Studies
    • Events
    • Podcast
    • Events
    • Podcast
  • Regulatory Updates
  • Resources

    Regulatory Updates

    Subscribe to the Regulatory Intelligence Digest to receive the latest guidance in medicines regulations

    Subscribe
    • Resources
    • Factsheets
    • Resources
    • Factsheets
    • Publications
    • Webinars
    • Publications
    • Webinars
Contact Us

Case Studies

Digital healthcare interface representing FDA submission and regulatory data management
Case Studies

Delivering a high-priority FDA submission: Regulatory Operations excellence under pressure

Read More »
November 5, 2025
MAA submission
Case Studies

End-to-end regulatory support for a gene therapy MAA submission

Read More »
September 16, 2025
BLA submission
Case Studies

Comprehensive regulatory support for a gene therapy BLA submission

Read More »
September 16, 2025
EU marketing authorization application
Case Studies

Expert and swift publishing support for an urgent EU Marketing Authorization Application

Read More »
October 21, 2024
Case Studies

Regulatory support for the development of a stem cell therapy and device for the treatment of Parkinson’s Disease

Read More »
October 26, 2023
Case Studies

Providing support for a phase 2 study in patients with metastatic breast cancer in the UK and EU

Read More »
August 16, 2023
« Previous Page1 Page2 Page3 Next »

Speak to a member of the team today

Contact Us

Contact Us

UK +44 (0)1270 270010
US +1 800 982 7431
E info@boydconsultants.com

Twitter Linkedin Youtube Spotify Apple

Services

  • Product Development
  • Regulatory Affairs
  • Clinical Operations
  • Clinical and Medical Affairs
  • Pharma Due Diligence
  • Regulatory Operations

Newsletter Sign-up

Sign up to our monthly newsletter to stay up to date with the latest news and views from Boyds.

Sign Up

Boyds is a trading name of Boyds International Life Sciences Group Limited registered in England and Wales. Registered Number: 13521126 © Boyds 2025. All Rights Reserved.

Privacy Policy      Contact

arrow